Taro Iwamoto

1.8k total citations
14 papers, 1.4k citations indexed

About

Taro Iwamoto is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Clinical Psychology. According to data from OpenAlex, Taro Iwamoto has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Clinical Psychology. Recurrent topics in Taro Iwamoto's work include Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (6 papers) and Pharmaceutical studies and practices (4 papers). Taro Iwamoto is often cited by papers focused on Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (6 papers) and Pharmaceutical studies and practices (4 papers). Taro Iwamoto collaborates with scholars based in United States, Japan and Belgium. Taro Iwamoto's co-authors include Robert D. McQuade, William H. Carson, Elyse Stock, Ronald N. Marcus, Stephen Kaplita, Margaretta Nyilas, Mirza W. Ali, Stephen R. Marder, Allan Z. Safferman and Anutosh Ranjan Saha and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Psychopharmacology.

In The Last Decade

Taro Iwamoto

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taro Iwamoto United States 10 1.2k 265 209 162 136 14 1.4k
Stuart Kushner United States 14 1.0k 0.9× 250 0.9× 208 1.0× 119 0.7× 75 0.6× 19 1.2k
Michelle Kramer United States 15 1.6k 1.4× 254 1.0× 172 0.8× 283 1.7× 147 1.1× 27 1.9k
Dan Zimbroff United States 12 890 0.7× 317 1.2× 117 0.6× 266 1.6× 134 1.0× 21 1.3k
Margaretta Nyilas United States 15 1.2k 1.0× 313 1.2× 184 0.9× 427 2.6× 120 0.9× 28 1.4k
Robert A. Leadbetter United States 15 984 0.8× 294 1.1× 186 0.9× 378 2.3× 87 0.6× 22 1.5k
Ludmila Kryzhanovskaya United States 17 830 0.7× 255 1.0× 149 0.7× 87 0.5× 48 0.4× 29 1.1k
David McDonnell United States 19 1.1k 0.9× 213 0.8× 119 0.6× 374 2.3× 123 0.9× 68 1.3k
Thomas J. Arndt United States 8 760 0.6× 147 0.6× 57 0.3× 171 1.1× 77 0.6× 8 1.1k
J. Street United States 10 1.4k 1.1× 278 1.0× 76 0.4× 354 2.2× 203 1.5× 29 1.6k
Lisa A. Arvanitis United States 14 1.4k 1.2× 283 1.1× 124 0.6× 377 2.3× 134 1.0× 34 1.8k

Countries citing papers authored by Taro Iwamoto

Since Specialization
Citations

This map shows the geographic impact of Taro Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Iwamoto more than expected).

Fields of papers citing papers by Taro Iwamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Iwamoto. The network helps show where Taro Iwamoto may publish in the future.

Co-authorship network of co-authors of Taro Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Iwamoto. A scholar is included among the top collaborators of Taro Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Iwamoto. Taro Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Robb, Adelaide S., William H. Carson, Margaretta Nyilas, et al.. (2010). Changes in Positive and Negative Syndrome Scale–Derived Hostility Factor in Adolescents with Schizophrenia Treated with Aripiprazole: Post Hoc Analysis of Randomized Clinical Trial Data. Journal of Child and Adolescent Psychopharmacology. 20(1). 33–38. 12 indexed citations
2.
Findling, Robert L., Ralph E. Kauffman, Floyd R. Sallee, et al.. (2009). An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder. Journal of Child and Adolescent Psychopharmacology. 19(4). 431–439. 38 indexed citations
3.
Findling, Robert L., Margaretta Nyilas, Robert A. Forbes, et al.. (2009). Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole. The Journal of Clinical Psychiatry. 70(10). 1441–1451. 140 indexed citations
4.
Findling, Robert L., Adelaide S. Robb, Margaretta Nyilas, et al.. (2008). A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia. American Journal of Psychiatry. 165(11). 1432–1441. 194 indexed citations
5.
Nyilas, Margaretta, Robert A. Forbes, Na Jin, et al.. (2008). LONG-TERM TOLERABILITY AND SAFETY OF ARIPIPRAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER. Schizophrenia Research. 102(1-3). 243–243. 1 indexed citations
6.
7.
Sachs, Gary, Raymond Sanchez, Ronald N. Marcus, et al.. (2006). Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. Journal of Psychopharmacology. 20(4). 536–546. 190 indexed citations
8.
9.
Vieta, Eduard, Michel Bourin, Raymond Sanchez, et al.. (2005). Effectiveness of aripiprazole v. Haloperidol in acute bipolar mania. The British Journal of Psychiatry. 187(3). 235–242. 137 indexed citations
10.
Deyn, Peter Paul De, Dilip V. Jeste, René Swanink, et al.. (2005). Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease. Journal of Clinical Psychopharmacology. 25(5). 463–467. 112 indexed citations
11.
Kujawa, Mary J., Ronald N. Marcus, Christopher D. Breder, et al.. (2004). P1-306 Safety and tolerability profile of aripiprazole in elderly patients with psychosis of Alzheimer's disease: a pooled analysis. Neurobiology of Aging. 25. S183–S183. 1 indexed citations
12.
Streim, Joel E., Christopher D. Breder, René Swanink, et al.. (2004). P1-330 Flexible-dose aripiprazole in psychosis of Alzheimer's disease. Neurobiology of Aging. 25. S191–S191. 5 indexed citations
13.
Breder, Christopher D., René Swanink, Ronald N. Marcus, et al.. (2004). P1-326 Dose-ranging study of aripiprazole in patients with dementia of Alzheimer's disease. Neurobiology of Aging. 25. S190–S190. 3 indexed citations
14.
Marder, Stephen R., Robert D. McQuade, Elyse Stock, et al.. (2003). Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophrenia Research. 61(2-3). 123–136. 374 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart Kushner Breakdown of academic impact, for papers by Michelle Kramer Breakdown of academic impact, for papers by Dan Zimbroff Breakdown of academic impact, for papers by Margaretta Nyilas Breakdown of academic impact, for papers by Robert A. Leadbetter Breakdown of academic impact, for papers by Ludmila Kryzhanovskaya Breakdown of academic impact, for papers by David McDonnell Breakdown of academic impact, for papers by Thomas J. Arndt Breakdown of academic impact, for papers by J. Street Breakdown of academic impact, for papers by Lisa A. Arvanitis
Rankless by CCL
2026